IMMUNE THERAPEUTICS THAT COMBINE FAST-ACTING MONOCLONAL ANTIBODY AND A VACCINE FOR LONG-LASTING PROTECTION AGAINST PLASMODIUM FALCIPARUM MALARIA
$1,672,094FY2022Defense Health AgencyDOD
The Geneva Foundation
Investigators
View source on USAspending →IMMUNE THERAPEUTICS THAT COMBINE FAST-ACTING MONOCLONAL ANTIBODY AND A VACCINE FOR LONG-LASTING PROTECTION AGAINST PLASMODIUM FALCIPARUM MALARIA · GrantIndex